Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
D.I. Shmidt
Observed names:
D. I. Shmidt,
D. Shmidt,
Daniil I. Shmidt,
Daniil Shmidt,
Шмидт Д.И.
Institution:
Baylor College of Medicine
Observed institutions:
Baylor College of Medicine,
First Pavlov State Medical University of St. Petersburg,
Texas Children's Hospital
ORCID:
0000-0003-4600-4309
Observed ORCID:
0000-0003-4600-4309
OpenAlex ID:
A5009408136
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity
2024
·
Royce Ma
, Mae Woods
, et al.
·
Cell Reports Medicine
·
25
Nivolumab in Primary CNS Lymphoma and Primary Testicular Lymphoma with CNS Involvement: Single Center Experience
2020
·
Andrey N. Gavrilenko
, Nikita P. Volkov
, et al.
·
Blood
·
25
SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
2024
·
Daniil Shmidt
, Maksim Mamonkin
·
Clinical Lymphoma Myeloma & Leukemia
·
4
PDF
Pb2308: Nivolumab-based Therapy of Relapsed or Refractory Primary Large B-cell Lymphoma of Immune-privileged Sites and Dlbcl With Secondary Cns Involvement
2023
·
Andrey Gavrilenko
, Vladislav Markelov
, et al.
·
HemaSphere
·
3
CLL-1 chimeric antigen receptor T-cells for the treatment of Acute Myeloid Leukemia: A phase 1 clinical trial
2025
·
Erin Doherty
, LaQuisa Hill
, et al.
·
Blood
·
2
Invasive fungal infection of the central nervous system caused by rare yeast pathogen Malassezia spp. in patients with acute leukemia: case reports and literature review
2021
·
Yu. A. Rogacheva
, M. O. Popova
, et al.
·
The Scientific Notes of the Pavlov University
·
2
PDF
Pb1816 Nivolumab Treatment for Relapsed and Refractory Primary Central Nervous System Lymphoma and Primary Testicular Lymphoma With Cns Involvement
2019
·
D. Shmidt
, G. Andrey
, et al.
·
HemaSphere
·
2
903P Combination of nivolumab with brentuximab vedotin in therapy of relapsed and refractory Hodgkin lymphoma
2020
·
L. Fedorova
, K. Lepik
, et al.
·
Annals of Oncology
·
1
Checkpoint inhibitors and conventional therapy for central nervous system lymphoma
2019
·
D.I. Shmidt
, A.N. Gavrilenko
, et al.
·
Annals of Oncology
·
1
EXABS-135-ALL Development of CAR T-Cells for T-ALL and LBL
2023
·
Daniil Shmidt
, Maksim Mamonkin
·
Clinical Lymphoma Myeloma & Leukemia
834P Role of assessment of IL-6, IL-15 and soluble PD-L1 levels as prognostic and predictive biomarkers in nivolumab-treated relapsed/refractory Hodgkin lymphoma
2021
·
A. Chekalov
, D. Shmidt
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
12
Citation count:
65
H-index:
3
I10-index:
2
Year
Topic
Type